CompanyDrug

Akeso Biopharma Completes Enrollment for AK112 Phase III Study

CompanyDrug

Eccogene Gains FDA Approval for Phase I Study of ECC5004

CompanyDrug

BeiGene’s Brukinsa Receives EU Marketing Approval for Marginal Zone Lymphoma

CompanyDeals

Dartsbio Licenses Potential First-in-Class BsAb DS005 to Duality Biologics

CompanyDeals

Fosun Pharma Terminates Equity Transfer Deal with OncoCare Medical

CompanyDrug

Antengene’s CD73 Inhibitor ATG-037 Greenlit for Phase I Study by NMPA

CompanyMedical Device

Sino Medical Sciences’ Non-Compliant Balloon Catheter Approved by NMPA

CompanyDrug

Hengrui’s Pyrotinib Granted Breakthrough Therapy Designation by CDE

CompanyDrug

NMPA Approves Humanwell’s Generic Clobazam for Lennox-Gastaut Syndrome

CompanyDrug

NMPA Approves Luye Pharma’s LY03005 for Depression Treatment

CompanyDrug

Shanghai SMPA Suspends HEC’s Linagliptin Procurement Over Patent Infringement

CompanyDrug

Shanghai Pharmaceuticals Gets NMPA Clearance for Sublingual Rasagiline